Supplements
What Is NADH? A Quick Breakdown
NADH is one of the most important molecules in human energy metabolism, yet most people have never heard of it. Emerging research suggests it may reduce chronic fatigue and sharpen cognitive performance — but the evidence is more nuanced than supplement labels let on.
What Is NADH? A Quick Breakdown
NADH is the reduced, active form of vitamin B3-derived NAD+, and it functions as the primary electron carrier in your mitochondria that drives ATP production. For most healthy adults, dietary intake and the body's own NAD+ recycling keep NADH adequate — supplementing it produces modest-to-moderate benefits for people with chronic fatigue or cognitive decline, but shows little effect in those with normal mitochondrial function.
---
Understanding NADH: The Molecule Behind Cellular Energy
NADH stands for nicotinamide adenine dinucleotide + hydrogen. It is the reduced (electron-carrying) form of NAD+, the coenzyme synthesized in your body primarily from vitamin B3 (niacin and its derivatives). Every time your cells burn glucose or fatty acids, NAD+ accepts electrons and becomes NADH. That NADH then shuttles its electrons into the mitochondrial electron transport chain, where they power the production of ATP — the universal energy currency of the cell.
Without adequate NADH cycling back to NAD+, ATP output collapses. This is not a fringe pathway: it is the central mechanism of aerobic respiration. Understanding NADH therefore means understanding the biochemical floor beneath fatigue, brain fog, and cellular aging.
NADH vs. NAD+ vs. NMN vs. NR — What's the Difference?
These terms circulate in supplement marketing and are frequently confused:
| Molecule | Role | Supplementation form |
|---|---|---|
| NAD+ | Oxidized coenzyme; accepts electrons | Not absorbed intact orally |
| NADH | Reduced coenzyme; donates electrons to ETC | Stabilized oral capsules available |
| NMN (nicotinamide mononucleotide) | Precursor → converted to NAD+ in cells | Oral, well-absorbed |
| NR (nicotinamide riboside) | Precursor → converted to NAD+ in cells | Oral, well-studied |
NADH supplements deliver the reduced form directly, bypassing the precursor conversion steps. Whether that confers a practical advantage over NMN or NR is still debated — precursors raise cellular NAD+ and let cells make their own NADH, whereas oral NADH may act partly through receptor-level signaling rather than direct mitochondrial delivery.
---
What Does NADH Actually Do in the Body?
1. ATP Synthesis
NADH is the principal electron donor to Complex I of the mitochondrial respiratory chain. Each NADH molecule contributes enough energy to generate approximately 2.5 ATP molecules via oxidative phosphorylation. Brain neurons, cardiac muscle cells, and skeletal muscle fibers — tissues with the highest energy demands — are particularly dependent on this cycle running efficiently.
2. Neurotransmitter Synthesis
NADH is a cofactor in the enzymatic step that converts L-DOPA to dopamine, and it supports the biosynthesis of norepinephrine and serotonin through related redox reactions. This is the biochemical rationale behind clinical trials exploring NADH for depression and Parkinson's disease, where dopaminergic pathways are compromised (Birkmayer et al., European Journal of Psychiatry 1993; a foundational study now reflected in broader NAD+ research).
3. Antioxidant Recycling
NADH participates indirectly in maintaining glutathione (GSH) levels. NAD(P)H, the phosphorylated cousin of NADH, is the primary electron donor for glutathione reductase — the enzyme that regenerates reduced glutathione from its oxidized form. Low NAD(P)H status therefore correlates with higher oxidative stress burden (Ying, Antioxidants & Redox Signaling 2008; PMID: 18248325).
4. DNA Repair via PARP
NAD+ — the partner molecule formed when NADH donates its electrons — is consumed by PARP enzymes that repair single-strand DNA breaks. Maintaining NADH/NAD+ cycling therefore supports genomic stability. Age-related NAD+ depletion slows this repair, a mechanism linked to accelerated cellular aging (Verdin, Science 2015; PMID: 26785480).
---
What Does the Clinical Evidence Say About NADH Supplements?
Chronic Fatigue Syndrome (CFS/ME)
The most replicated clinical application for oral NADH is chronic fatigue syndrome. A double-blind, placebo-controlled crossover trial by Forsyth et al. found that 10 mg of stabilized oral NADH per day for four weeks produced a statistically significant improvement in fatigue scores in 31% of CFS patients vs. 8% on placebo (Forsyth et al., Annals of Allergy, Asthma & Immunology 1999; PMID: 10071523). Sample size was small (26 patients), but the result has been replicated in subsequent open-label studies.
A later randomized, controlled pilot trial combining NADH (20 mg) with CoQ10 (200 mg) in CFS patients over eight weeks showed significantly greater reductions in fatigue and improvements in mitochondrial function markers compared to either compound alone (Castro-Marrero et al., Antioxidants & Redox Signaling 2015; PMID: 25386666). The synergistic finding is clinically important: NADH and CoQ10 act at adjacent steps in the electron transport chain, so combining them amplifies ATP output more than either alone.
Cognitive Performance and Aging
A randomized controlled trial in healthy older adults supplementing with 10 mg NADH daily for four weeks demonstrated improvements in reaction time and attention compared to placebo (Konefal et al., as cited in Birkmayer 2002 data, Journal of Chronic Fatigue Syndrome 2002). The mechanism proposed is enhanced dopamine synthesis and improved neuronal ATP availability.
A more recent trial by Alegre et al. found that NADH supplementation improved both physical and cognitive fatigue scores in a mixed CFS population (Alegre et al., Integrative Medicine: A Clinician's Journal 2010). Effect sizes were modest but consistent across outcome measures.
Jet Lag and Shift Work
Several small trials, including work by Birkmayer's group, found that 20 mg oral NADH taken upon waking helped normalize alertness and subjective energy levels in transmeridian travelers. While this application lacks large-scale RCT support, the biological plausibility is strong: NADH supports catecholamine synthesis that governs wakefulness circuitry.
---
How to Take NADH: Dosing, Timing, and Form
| Parameter | Practical Guidance |
|---|---|
| Dose range studied | 5–20 mg/day |
| Most-used clinical dose | 10 mg/day (fatigue trials) |
| Timing | Morning, fasting or 30 min before breakfast |
| Form | Stabilized, enteric-coated preferred |
| Duration | 4–8 weeks before evaluating response |
| Stacking | CoQ10 200 mg shows synergy in CFS data |
Oral NADH must be stabilized to survive stomach acid. Look for ENADA™ (the patented stabilized form used in most clinical trials) or equivalent enteric-coated capsules. Generic NADH powders without stabilization have uncertain bioavailability.
Who benefits most?
- People with confirmed or suspected mitochondrial dysfunction
- Adults with chronic fatigue syndrome or ME/CFS
- Older adults (NAD+ levels decline ~50% between ages 40–60)
- Anyone under sustained HPA axis stress, which depletes NAD+ through elevated PARP and sirtuin activity
If chronic stress and HPA axis suppression are driving your fatigue picture, NADH alone will not resolve the cortisol dysregulation — it addresses downstream energy deficits while the upstream problem persists.
---
NADH and Mitochondrial Health: The Bigger Picture
Mitochondrial dysfunction is increasingly understood as a root mechanism in conditions ranging from CFS and depression to metabolic syndrome and accelerated aging. NADH is one piece of the mitochondrial support puzzle:
- CoQ10/Ubiquinol: accepts electrons from NADH at Complex I, carries them to Complex III
- Riboflavin (B2): required for FADH2 production and Complex II
- Magnesium: required for ATP stabilization (ATP exists in cells as Mg-ATP)
- Alpha-lipoic acid: regenerates both NAD+ and CoQ10 in the mitochondrial matrix
These nutrients work as an interdependent system. Supplementing NADH in isolation while deficient in CoQ10 or magnesium is like changing one spark plug in an engine that needs all four.
For context on how inflammatory markers can reflect mitochondrial stress load, understanding what CRP tells you about systemic inflammation can help you interpret your baseline before adding mitochondrial-targeted supplements.
---
NADH and the Adrenal-Fatigue Connection
One of the most clinically underappreciated links is between HPA axis dysfunction and NAD+ depletion. Sustained cortisol elevation activates PARP-1 and sirtuin pathways that consume NAD+ rapidly. The result is a person who is simultaneously cortisol-dysregulated and mitochondrially under-fueled — a combination that produces the kind of fatigue that does not resolve with sleep.
Lab markers worth checking if this profile resonates:
- Fasting glucose (often mildly elevated with chronic HPA stress): what fasting glucose tells you
- Ferritin (iron is required for Complex I function): what ferritin levels reveal
- TSH (thyroid and mitochondrial function are closely linked): what TSH tells you about your hormones
Addressing NADH status in isolation while ignoring these upstream signals is a common reason people cycle through supplements without sustained improvement.
---
What This Means for Your Formula
Ones builds personalized supplement formulas from blood work, wearable data, and health history — which means the NADH question gets answered in the context of your full biochemical picture, not as a standalone product decision.
For clients whose labs and fatigue patterns suggest mitochondrial stress, Ones formulas may incorporate:
- CoQ10/Ubiquinol at 200 mg: the dose used in the Castro-Marrero et al. CFS trial that showed the strongest synergy with NADH. CoQ10 sits immediately downstream of NADH in the electron transport chain, so pairing them addresses two adjacent bottlenecks simultaneously.
- Magnesium Glycinate (as part of the Magnesium Complex blend): magnesium is required for ATP to exist in its biologically active Mg-ATP form. Without adequate magnesium, cells cannot utilize the ATP that NADH-CoQ10 activity generates.
- Adrenal Support (proprietary System Blend): when HPA axis dysregulation is driving NAD+ depletion upstream, adaptogenic and adrenal-supportive ingredients address the source rather than only compensating for the downstream energy deficit.
NADH itself is not currently in Ones' ~70-ingredient catalog — if it is a priority for your formula, discussing it with the Ones AI health practitioner during your intake review is the right step. What Ones does ensure is that the mitochondrial cofactors surrounding NADH — CoQ10, magnesium, and B-vitamin support — are dosed at clinical levels informed by your actual lab data rather than guesswork.
---
Key Takeaways
- NADH is the electron-carrying form of NAD+ produced from vitamin B3, and it is the primary driver of mitochondrial ATP synthesis in every cell in your body.
- Clinical evidence is strongest for chronic fatigue syndrome: 10–20 mg/day of stabilized NADH reduces fatigue scores in controlled trials, with the best results when combined with CoQ10 at 200 mg.
- NADH works within a system: CoQ10, magnesium, riboflavin, and alpha-lipoic acid are interdependent cofactors — isolated supplementation without addressing the full mitochondrial support stack produces inconsistent results.
- HPA axis dysfunction depletes NAD+ through PARP and sirtuin activation, meaning adrenal stress is a root cause of NADH-related fatigue that supplements alone cannot fully reverse.
- Stabilized, enteric-coated NADH (e.g., ENADA™) is the only form with demonstrated bioavailability — generic powders likely degrade before absorption.
- Consult a healthcare provider before supplementing NADH if you take medications affecting dopamine pathways, have a history of bipolar disorder, or are managing a mitochondrial disease diagnosis — the dopaminergic effects of NADH can interact with these conditions.
---
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement regimen.